Skip to search.
 All Ordinaries Up 0.78%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
2.33 Up 0.03(1.30%) 31 Mar 07:00
Add to Portfolio
Prev Close:2.30
Open:2.31
Bid:1.83 x 100
Ask:1.99 x 200
1y Target Est:8.75
Beta:1.72
Earnings Date:6 May - 11 May (Est.)
Day's Range:2.27 - 2.37
52wk Range:2.18 - 4.97
Volume:923,267
Avg Vol (3m):930,064
Market Cap:252.52M
P/E (ttm):N/A
EPS (ttm):-0.88
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTAUp 1.30%252.52M
INFIDown 0.21%700.53M
NVSUp 0.91%243.00B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.78
Quarterly EPS Est (Mar-15) :-0.20
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback